C. Mathis

发表

A basal stem cell signature identifies aggressive prostate cancer phenotypes

Joshua M. Stuart, R. Baertsch, Kiley Graim, 2015, Proceedings of the National Academy of Sciences.

Quantifying Biomass Changes of Single CD8+ T Cells during Antigen Specific Cytotoxicity

Michael A. Teitell, Daina Burnes, Thomas A. Zangle, 2013, PloS one.

Isolation and characterization of NY-ESO-1–specific T cell receptors restricted on various MHC molecules

D. Baltimore, A. Ribas, O. Witte, 2018, Proceedings of the National Academy of Sciences.

The Intraprostatic Immune Environment after Stereotactic Body Radiotherapy is Dominated by Myeloid Cells

A. Kishan, D. Elashoff, M. Steinberg, 2020, Prostate Cancer and Prostatic Diseases.

N-Myc Drives Neuroendocrine Prostate Cancer Initiated from Human Prostate Epithelial Cells.

Joshua M. Stuart, R. Baertsch, K. Shokat, 2016, Cancer cell.

Functional screen identifies kinases driving prostate cancer visceral and bone metastasis

Jiaoti Huang, O. Witte, C. Morrissey, 2015, Proceedings of the National Academy of Sciences.

The Current Status and Future Role of the Phosphoinositide 3 Kinase/AKT Signaling Pathway in Urothelial Cancer: An Old Pathway in the New Immunotherapy Era

A. Pantuck, K. Chamie, A. Drakaki, 2017, Clinical genitourinary cancer.

Modulating BET Bromodomain Inhibitor ZEN‐3694 and Enzalutamide Combination Dosing in a Metastatic Prostate Cancer Patient Using CURATE.AI, an Artificial Intelligence Platform

Dean Ho, Theodore Kee, Peter Wang, 2018, Advanced Therapeutics.

The intraprostatic immune environment after stereotactic body radiotherapy is dominated by myeloid cells

A. Kishan, M. Steinberg, P. Kupelian, 2020, Prostate Cancer and Prostatic Diseases.

Phase I Trial of Stereotactic Body Radiotherapy Neoadjuvant to Radical Prostatectomy for Patients with High-Risk Prostate Cancer.

A. Kishan, D. Elashoff, M. Steinberg, 2020, International journal of radiation oncology, biology, physics.